New studies find MOTS-c acts as an immune defender and PCOS marker

MOTS-c is a short protein encoded by mitochondrial DNA. Mitochondria are the energy centers of cells. MOTS-c has been studied for how cells handle stress and energy use ⁴. The three new studies add different angles. One looked at immune defense in cells and mice ¹. One measured MOTS-c in women with polycystic ovary syndrome, a hormone condition ². One tested a MOTS-c-based gel in a rat heart attack model ³.

MOTS-c can act like a host defense peptide. A host defense peptide is a small protein that attacks microbes and helps adjust immune cells. Many known host defense peptides come from nuclear DNA, but MOTS-c comes from mitochondrial DNA ¹. In laboratory tests, MOTS-c targeted Escherichia coli and methicillin-resistant Staphylococcus aureus, often called MRSA ¹. It did this in part by disrupting their membranes using hydrophobic and cationic regions, meaning water-repelling and positively charged parts ¹.

In a mouse model of acute peritonitis, a severe abdominal infection, MOTS-c fully neutralized MRSA infectivity ¹. In human monocytes, which are immune cells, signals such as interferon gamma and lipopolysaccharides induced the cells to produce their own MOTS-c ¹. When MOTS-c was added during the development of mouse monocytes into macrophages, the resulting macrophages cleared bacteria better and shifted their metabolism ¹. These changes were linked to genes involved in antigen presentation and interferon signaling ¹.

Women with polycystic ovary syndrome had lower MOTS-c than matched controls. The study compared forty women with PCOS and forty healthy women matched for age and body mass index ². The PCOS group had lower circulating MOTS-c, 220.2 pg/mL versus 498.3 pg/mL on average ². A smaller muscle biopsy group showed lower skeletal muscle MOTS-c expression as well, 74.2 versus 100.0 arbitrary units ². Lower serum MOTS-c was also associated with higher total testosterone and higher total cholesterol ².

Because this was a cross-sectional study, it can show associations but not cause and effect. The authors describe the findings as evidence of disrupted mitochondrial peptide regulation in PCOS ². This pattern contrasts with earlier data in adults with obesity, where MOTS-c levels were higher, not lower ⁵.

One rat study tested a way to keep donor mitochondria alive long enough to help a damaged heart. Mitochondrial transplantation is an experimental idea, but isolated mitochondria are fragile and quickly lose function after removal ³. Researchers linked MOTS-c to a self-assembling peptide to create a gel that holds and protects mitochondria ³.

In laboratory conditions, the gel extended the survival of isolated mitochondria and maintained metabolic enzyme activity for at least eight hours ³. It also shielded donor mitochondria from oxidative stress and calcium overload, and it helped macrophages take up the mitochondria through an AMPK-dependent mechanism ³. AMPK is a cellular energy sensor ⁶. In a rat heart attack model, the gel with mitochondria reduced pro-inflammatory macrophage infiltration and heart cell damage, improved heart function, and limited harmful remodeling ³. This was a delivery platform, not a test of MOTS-c alone as a heart treatment in people.

Each study asked a different question and used a different design.

The three studies do not test the same outcome. One tests immune defense, one tests hormone differences, and one tests delivery.

These three studies sit alongside a larger body of MOTS-c research. Earlier animal studies linked MOTS-c to protection in lung, heart, muscle, and metabolic models ⁴. Human observational studies have linked circulating MOTS-c levels to conditions such as obesity, diabetes, and cardiovascular stress ⁴. There are no human interventional trials yet ⁴.

The immune defense finding is new because most prior work focused on metabolic and tissue stress, not direct antimicrobial activity ¹. The PCOS finding adds a specific hormone condition to the list of states where MOTS-c levels differ from healthy people ². The hydrogel study shows a possible experimental use for MOTS-c to improve mitochondrial transplantation, a technique that is not established in human medicine ³.

MOTS-c is often studied alongside humanin, another mitochondrial-derived peptide. Both appear in models of cardiac fibrosis and mitochondrial dysfunction ⁸. That connection supports the idea that mitochondrial peptides can have overlapping repair and signaling roles, though the new immune function is more distinct to MOTS-c in this work ¹.

The immune defense work was in cells and mice, so whether MOTS-c protects against infections in humans is unknown ¹. The PCOS study was cross-sectional, so it cannot show whether low MOTS-c contributes to the condition ². The heart study was in rats, and the hydrogel platform has not been tested in people ³. None of these studies establishes a human treatment effect. In the research so far, MOTS-c appears to be a stress-response peptide with newly described immune and delivery roles, but all three findings sit outside human interventional evidence.